These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 12654612)

  • 1. Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability.
    Eriksson A; Cao R; Roy J; Tritsaris K; Wahlestedt C; Dissing S; Thyberg J; Cao Y
    Circulation; 2003 Mar; 107(11):1532-8. PubMed ID: 12654612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF.
    Cao R; Brakenhielm E; Wahlestedt C; Thyberg J; Cao Y
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6390-5. PubMed ID: 11344271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability.
    Cao R; Eriksson A; Kubo H; Alitalo K; Cao Y; Thyberg J
    Circ Res; 2004 Mar; 94(5):664-70. PubMed ID: 14739162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.
    Murohara T; Horowitz JR; Silver M; Tsurumi Y; Chen D; Sullivan A; Isner JM
    Circulation; 1998 Jan 6-13; 97(1):99-107. PubMed ID: 9443437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
    Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
    Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38 MAP kinase--a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability.
    Issbrücker K; Marti HH; Hippenstiel S; Springmann G; Voswinckel R; Gaumann A; Breier G; Drexler HC; Suttorp N; Clauss M
    FASEB J; 2003 Feb; 17(2):262-4. PubMed ID: 12490545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt signaling mediates VEGF/VPF vascular permeability in vivo.
    Six I; Kureishi Y; Luo Z; Walsh K
    FEBS Lett; 2002 Dec; 532(1-2):67-9. PubMed ID: 12459464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis.
    Ushio-Fukai M; Tang Y; Fukai T; Dikalov SI; Ma Y; Fujimoto M; Quinn MT; Pagano PJ; Johnson C; Alexander RW
    Circ Res; 2002 Dec; 91(12):1160-7. PubMed ID: 12480817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
    Gélinas DS; Bernatchez PN; Rollin S; Bazan NG; Sirois MG
    Br J Pharmacol; 2002 Dec; 137(7):1021-30. PubMed ID: 12429574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
    Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability.
    Spyridopoulos I; Luedemann C; Chen D; Kearney M; Chen D; Murohara T; Principe N; Isner JM; Losordo DW
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):901-6. PubMed ID: 12067896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterotrimeric G alpha q/G alpha 11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling.
    Zeng H; Zhao D; Yang S; Datta K; Mukhopadhyay D
    J Biol Chem; 2003 Jun; 278(23):20738-45. PubMed ID: 12670961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF-induced permeability increase is mediated by caveolae.
    Feng Y; Venema VJ; Venema RC; Tsai N; Behzadian MA; Caldwell RB
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):157-67. PubMed ID: 9888439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor induces protein kinase C (PKC)-dependent Akt/PKB activation and phosphatidylinositol 3'-kinase-mediates PKC delta phosphorylation: role of PKC in angiogenesis.
    Gliki G; Wheeler-Jones C; Zachary I
    Cell Biol Int; 2002; 26(9):751-9. PubMed ID: 12377207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho family GTPases regulate VEGF-stimulated endothelial cell motility.
    Soga N; Namba N; McAllister S; Cornelius L; Teitelbaum SL; Dowdy SF; Kawamura J; Hruska KA
    Exp Cell Res; 2001 Sep; 269(1):73-87. PubMed ID: 11525641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade.
    Pal S; Iruela-Arispe ML; Harvey VS; Zeng H; Nagy JA; Dvorak HF; Mukhopadhyay D
    Microvasc Res; 2000 Sep; 60(2):112-20. PubMed ID: 10964585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
    Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.
    Salcedo R; Wasserman K; Young HA; Grimm MC; Howard OM; Anver MR; Kleinman HK; Murphy WJ; Oppenheim JJ
    Am J Pathol; 1999 Apr; 154(4):1125-35. PubMed ID: 10233851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.